S66 Stock Overview
Engages in the manufacturing and distribution of health food products and nutritional supplements in Australia and China. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
My Notes
Capture your thoughts, links and company narrative
Star Combo Pharma Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.14 |
| 52 Week High | AU$0.17 |
| 52 Week Low | AU$0.10 |
| Beta | 0.45 |
| 1 Month Change | 0% |
| 3 Month Change | -6.67% |
| 1 Year Change | -3.45% |
| 3 Year Change | -45.10% |
| 5 Year Change | -69.57% |
| Change since IPO | -82.28% |
Recent News & Updates
Some Star Combo Pharma Limited (ASX:S66) Shareholders Look For Exit As Shares Take 31% Pounding
Nov 11
Star Combo Pharma Limited's (ASX:S66) 30% Share Price Surge Not Quite Adding Up
Aug 23Recent updates
Some Star Combo Pharma Limited (ASX:S66) Shareholders Look For Exit As Shares Take 31% Pounding
Nov 11Star Combo Pharma Limited's (ASX:S66) 30% Share Price Surge Not Quite Adding Up
Aug 23Star Combo Pharma (ASX:S66) Might Have The Makings Of A Multi-Bagger
Aug 13Star Combo Pharma Limited's (ASX:S66) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Jun 12Star Combo Pharma (ASX:S66) Is Doing The Right Things To Multiply Its Share Price
May 12Star Combo Pharma Limited's (ASX:S66) Shares May Have Run Too Fast Too Soon
Mar 20Should Shareholders Have Second Thoughts About A Pay Rise For Star Combo Pharma Limited's (ASX:S66) CEO This Year?
Nov 21Star Combo Pharma's (ASX:S66) Robust Earnings Might Be Weaker Than You Think
Mar 02Rock star Growth Puts Star Combo Pharma (ASX:S66) In A Position To Use Debt
Dec 24
Shareholder Returns
| S66 | AU Personal Products | AU Market | |
|---|---|---|---|
| 7D | 3.7% | 8.3% | 0.5% |
| 1Y | -3.4% | 32.1% | 7.4% |
Return vs Industry: S66 underperformed the Australian Personal Products industry which returned 27.7% over the past year.
Return vs Market: S66 underperformed the Australian Market which returned 7.7% over the past year.
Price Volatility
| S66 volatility | |
|---|---|
| S66 Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 5.9% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in AU Market | 16.9% |
| 10% least volatile stocks in AU Market | 3.0% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine S66's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | n/a | Su Zhang | www.starcombo.com.au |
Star Combo Pharma Limited engages in the manufacturing and distribution of health food products and nutritional supplements in Australia and China. It operates in two segments, OEM Division and Austoyou Retail. The company develops, manufactures, markets, and sells natural health supplements and skin care products.
Star Combo Pharma Limited Fundamentals Summary
| S66 fundamental statistics | |
|---|---|
| Market cap | AU$18.91m |
| Earnings (TTM) | AU$747.33k |
| Revenue (TTM) | AU$26.02m |
25.3x
P/E Ratio0.7x
P/S RatioIs S66 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| S66 income statement (TTM) | |
|---|---|
| Revenue | AU$26.02m |
| Cost of Revenue | AU$20.30m |
| Gross Profit | AU$5.71m |
| Other Expenses | AU$4.97m |
| Earnings | AU$747.33k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0055 |
| Gross Margin | 21.96% |
| Net Profit Margin | 2.87% |
| Debt/Equity Ratio | 0.03% |
How did S66 perform over the long term?
See historical performance and comparisonDividends
2.6%
Current Dividend Yield67%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 23:40 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Star Combo Pharma Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|